Treating Neuroendocrine Tumors: Somatostatin Analogs

Heloisa P. Soares, MD, provides a comprehensive outline of available regimens for the management of neuroendocrine tumors, elucidating the value of somatostatin analogs.
PUBLISHED January 30, 2018

Related Articles


Sign In

Not a member? Sign up now!

Sign Up

Are you a member? Please Log In